ESR1 and triple-negative breast carcinoma: The MDA-MB-231 cell line has been used to study triple-negative breast cancers (TNBC), which is a mesenchymal type of stem cells and characterized by lack of estrogenic receptor (ER) and progesterone receptor (PR) and HER2 protein overexpression [17, 32].